Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.718
+0.018 (2.59%)
At close: Nov 20, 2024, 4:00 PM
0.690
-0.028 (-3.86%)
After-hours: Nov 20, 2024, 6:44 PM EST
Equillium Employees
Equillium had 44 employees as of December 31, 2023. The number of employees increased by 8 or 22.22% compared to the previous year.
Employees
44
Change (1Y)
8
Growth (1Y)
22.22%
Revenue / Employee
$1,043,500
Profits / Employee
-$104,886
Market Cap
25.44M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Allurion Technologies | 504 |
DarioHealth | 294 |
Neuronetics | 203 |
Tonix Pharmaceuticals Holding | 103 |
BioXcel Therapeutics | 74 |
Athira Pharma | 67 |
Inspira Technologies Oxy B.H.N. | 42 |
Pulmatrix | 22 |
EQ News
- 7 days ago - Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates - Business Wire
- 8 days ago - Equillium to Present at the Stifel Healthcare Conference - Business Wire
- 9 days ago - Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer - Business Wire
- 21 days ago - Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire
- 6 weeks ago - Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer - Business Wire
- 2 months ago - Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit - Business Wire
- 2 months ago - Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference - Business Wire